Trevi Therapeutics, Inc.
TRVI
$14.76
-$0.12-0.81%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 66.36% | 74.93% | 197.63% | 193.38% | 41.80% |
| Total Receivables | 139.13% | 85.34% | 322.11% | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 44.84% | 34.50% | 16.92% | -2.11% | -52.56% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 173.26% | 242.39% | 107.85% | -10.48% | -48.13% |
| Total Current Assets | 66.75% | 75.14% | 194.49% | 187.30% | 37.59% |
|
|
|||||
| Total Current Assets | 66.75% | 75.14% | 194.49% | 187.30% | 37.59% |
| Net Property, Plant & Equipment | -23.38% | -30.43% | -27.51% | -25.92% | -22.94% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 982.99% | 281.89% | -59.77% | -75.09% | -22.51% |
| Total Assets | 67.85% | 74.43% | 189.31% | 182.26% | 36.21% |
|
|
|||||
| Total Accounts Payable | 55.88% | 14.56% | 67.84% | 96.82% | -32.72% |
| Total Accrued Expenses | -11.36% | -18.78% | -16.31% | 21.27% | 81.88% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 15.22% | 7.72% | -0.34% | -7.44% | -14.29% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 3.63% | -7.23% | -0.90% | 36.86% | 30.14% |
|
|
|||||
| Total Current Liabilities | 3.63% | -7.23% | -0.90% | 36.86% | 30.14% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -46.55% | -40.29% | -35.42% | -31.56% | -28.24% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -0.90% | -9.43% | -3.73% | 28.94% | 21.24% |
|
|
|||||
| Common Stock & APIC | 29.88% | 32.66% | 52.86% | 54.62% | 23.05% |
| Retained Earnings | -15.34% | -14.90% | -16.64% | -18.03% | -18.94% |
| Treasury Stock & Other | -360.27% | 142.62% | -78.42% | 128.57% | 208.96% |
| Total Common Equity | 73.07% | 83.90% | 221.84% | 199.96% | 37.50% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 73.07% | 83.90% | 221.84% | 199.96% | 37.50% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 73.07% | 83.90% | 221.84% | 199.96% | 37.50% |
|
|
|||||